IDA KHODAMI

Ida Khodami is a Partner at Two Bear Capital (TBC) where she leads investments in genomics, personalized medicine and biotechnology companies. Ida partners with portfolio companies to develop their strategies and growth plans and is currently an advisor to several ones including TileDB, Spiral Genetics, Expesicor, Truwl, FYR Diagnostics and XIX.ai.

Prior to TBC, Ida was at Illumina, a leading biotechnology company in San Diego, where she held multiple leadership positions across Engineering and Operations for over a decade. She built and led the first company validation consortium that resulted in FDA approval for the first ever Next-Generation-Sequencing platform: MiSeqDX. Before joining Illumina, Ida was the founder and CEO of a biomedical device company for vein detection. Ida holds a patent in her name for this invention, and through this experience, found her passion for leveraging technology to improve human health.

Ida has a MSc from University of Waterloo in Electrical Engineering and Computer Science. She is passionate about learning, interdisciplinary innovation, and helping the next generation of women leaders realize their vision and create positive impact.